A prospective evaluation of catheter ablation of ventricular tachycardia as adjuvant therapy in patients with coronary artery disease and an implantable cardioverter-defibrillator

Circulation

Volumn 96, Issue 5, 1997, Pages 1525-1531

  Strickberger, S Adam ^a,b   Man, K Ching ^a   Daoud, Emile G ^a   Goyal, Rajiva ^a   Brinkman, Karin ^a   Hasse, Carol ^a   Bogun, Frank ^a   Knight, Bradley P ^a   Weiss, Raul ^a   Bahu, Marwan ^a   Morady, Fred ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Catheter ablation; Coronary artery disease; Implantable cardioverter defibrillator; Tachycardia

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BRETYLIUM; FLECAINIDE; LIDOCAINE; METOPROLOL; MEXILETINE; MORACIZINE; PROCAINAMIDE; PROPAFENONE; QUINIDINE; SOTALOL; TOCAINIDE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVERSION; CATHETER ABLATION; CLINICAL ARTICLE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DEFIBRILLATION; FEMALE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTATION; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 0030782970     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.5.1525     Document Type: Article

References (28)

1. Tchou PJ, Kadri N, Anderson J, Caceres JA, Jazaveri M, Akhtar M. Automatic implantable cardioverter defibrillators and survival of patients with left ventricular dysfunction and malignant ventricular arrhythmias. Ann Intern Med. 1988;109:529-534.
2. Kelly PA, Cannom DS, Garan H, Mirabal GS, Harthorne JW, Hurvitz RJ, Vlahakes GJ, Jacobs ML, Ilvento JP. The automatic implantable cardioverter-defibrillator: efficacy, complications and survival in patients with malignant ventricular arrhythmias. J Am Coll Cardiol. 1988;11:1278-1286.
3. Winkle RA, Mead RH, Ruder MA, Gaudiani VA, Smith NA, Buch WS, Schmidt P, Shipman T. Long-term outcome with the automatic implantable cardioverter defibrillator. J Am Coll Cardiol. 1989;13: 1353-1361.
4. Myerburg RJ, Luceri RM, Thurer R, Cooper DK, Zaman L, Interian A, Fernandez P, Cox M, Glicksman F, Castellanos A. Time to first shock and clinical outcome in patients receiving an automatic implantable cardioverter-defibrillator. J Am Coll Cardiol. 1989;14:508-514.
5. Levine JH, Mellits ED, Baumgardner RA, Veltri EP, Mower M, Grunwald L, Guanieri T, Aarons D, Griffith LS. Predictors of first discharge and subsequent survivals in patients with automatic implantable cardioverter defibrillators. Circulation. 1991;84: 558-566.
6. Morady F, Harvey M, Kalbfleisch SJ, El-Atassi R, Calkins H, Langberg JJ. Radiofrequency catheter ablation of ventricular tachycardia in patients with coronary artery disease. Circulation. 1993;87:363-372.
7. Stevenson WG, Khan H, Sager P, Saxon LA, Middlekauff HR, Natterson PD, Wiener I. Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction. Circulation. 1993;88: 1647-1670.
8. Kim YH, Sosa-Surez G, Trouton TG, O'Nunain SS, Osswald S, McGovern BA, Ruskin JN, Garan H. Treatment of ventricular tachycardia by transcatheter radiofrequency ablation in patients with ischemic heart disease. Circulation. 1994;89:1094-1102.
9. Willems S, Borggrefe M, Shenasa M, Chen X, Hindricks G, Haverkamp W, Wietholt D, Block M, Beithardt G. Radiofrequency catheter ablation of ventricular tachycardia following implantation of an automatic cardioverter defibrillator. PACE. 1993; 16:1684-1692.
10. Gursoy S, Chiladakis I, Kuck KH. First lessons from radiofrequency catheter ablation in patients with ventricular tachycardia. PACE. 1993;16:687-691.
11. Zipes DP, DiMarco JP, Gillette PC, Jackman WM, Myerburg RJ, Rahimtoola SH, Ritchie JL, Cheithlin MD, Garson A, Gibbon S. Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Intracardiac Electrophysiologic and Catheter Ablation Procedures), developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol. 1995;26:555-573.
12. Morady D, Kadish A, Rosenheck S, Calkins H, Kou WH, de Buitleir M, Sousa J. Concealed entrainment as a guide for catheter ablation of ventricular tachycardia in patients with prior myocardial infarction. J Am Coll Cardiol. 1991;17:678-689.
13. Waldo AL, Biblo LA, Carlson MDS. Clinical importance of entrainment. J Cardiovasc Electrophysiol. 1990;1:543-557.
14. Morady F, Frank R, Kou WH, Tonet JL, Nelson SD, Kounde S, de Buitleir M, Fontaine G. Identification and catheter ablation of slow conduction in the reentrant circuit of ventricular tachycardia in humans. J Am Coll Cardiol. 1988;11P:775-782.
15. Stevenson WG, Sager PT, Friedman PL. Entrainment techniques for mapping atrial and ventricular tachycardias. J Cardiovasc Electrophysiol. 1995;6:201-216.
16. El-Sherif N, Mehra R, Gough WB, Zeiler RH. Reentrant ventricular arrhythmias in the late myocardial infarction period: interruption of reentrant circuits by cryothermal techniques. Circulation. 1983;68:644-656.
17. Fitzgerald DM, Friday KH, Yeung-Lai-Wah A, Lazzara R, Jackman WM. Electrogram patterns predicting successful catheter ablation of ventricular tachycardia. Circulation. 1988;77:806-814.
18. Fitzgerald DM, Friday KF, Yeung-Lai-Wah JA, Bowman AJ, Lazzara R, Jackman WM. Myocardial regions of slow conduction participating in the reentrant circuit of multiple ventricular tachycardias: report on ten patients. J Cardiovasc Electrophysiol. 1991;2:193-206.
19. Josephson ME, Horowitz LN, Farshidi A, Spear JF, Kastor JA, Moore EN. Recurrent sustained ventricular tachycardia, II: endocardial mapping. Circulation. 1978;57:440-447.
20. Josephson ME, Horowitz LN, Spielman SR, Greenspan AM, Vandepol C, Harken AH. Comparison of endocardial catheter mapping with intraoperative mapping of ventricular tachycardia. Circulation. 1980;61:395-404.
21. Josephson ME, Harken AH, Horowitz LN. Long-term results of endocardial resection for sustained ventricular tachycardia in coronary disease patients. Am Heart J. 1982;104:51-57.
22. Stevenson WG, Weiss JN, Wiener I, Nadamanee K. Slow conduction in the infarct scar: relevance to the occurrence, detection, and ablation of ventricular reentry circuits resulting from myocardial infarction. Am Heart J. 1989;117:452-464.
23. Josephson ME, Waxman HL, Cain ME, Gardner MJ, Buxton AE. Ventricular activation during ventricular endocardial pacing, II: role of pace-mapping to localize origin of ventricular tachycardia. Am J Cardiol. 1982;50:11-22.
24. Langberg JJ, Calkins H, El-Atassi R, Burganelli M, Leon A, Kalbfleisch SJ, Morady F. Temperature monitoring during radiofrequency catheter ablation of accessory pathways. Circulation. 1992;86:1469-1474.
25. Strickberger SA, Ravi S, Daoud E, Neibauer M, Williamson BD, Man KC, Hummel JD, Morady F. The relationship between impedance and temperature during radiofrequency ablation of accessory pathways. Am Heart J. 1995;130:1026-1030.
26. Hummel DJ, Strickberger SA, Daoud E, Neibauer M, Bakr O, Man KC, Williamson BD, Morady F. Results and efficiency of programmed ventricular stimulation with four extrastimuli compared with one, two, and three extrastimuli. Circulation. 1994;90: 2827-2823.
27. Vitale MB, Funk M. Quality of life in younger persons with an implantable cardioverter defibrillator. Dimensions Crit Care Nursing. 1995;14:100-111.
28. Budien RS, Knotts-Dolson SM, Plumb VJ, Kay GN. Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias. Circulation. 1996;94:1585-1591.